MedTrace Logo

Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block for Tooth Extraction

NCT03225326 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-03-22

No results posted yet for this study

Summary

The purpose of this study was to investigate and compare pulpal anesthesia and cardiovascular parameters obtained with 0.6 ml of 4% articaine with epinephrine (1:100.000) for anterior and middle superior alveolar nerve (AMSA) block performed by standard and computer-controlled delivery for maxillary teeth extraction.

Conditions

  • Local Anesthesia

Interventions

DRUG

Computer controlled 4% articaine delivery by Anaeject

Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject)

DRUG

Conventional 4% articaine delivery by carpule syringe

Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Marija Milić, Research Associate · School of Dental Medicine, University of Belgrade

  • Vladimir Biočanin, Assistant Professor · Faculty of Pharmacy and Health, University of Travnik, Bosnia and Herzegovina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-06-30
Completion
2017-07-31

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03225326 on ClinicalTrials.gov